Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara C Tilley

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Stroke|October 15, 2005
Applying a phase II futility study design to therapeutic stroke trialsYuko Y Palesch, Barbara C Tilley, David L Sackett, et al.
Parkinsonism & Related Disorders|August 25, 2014
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRSJennifer G Goldman, Glenn T Stebbins, Vania Leung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Repeatable battery for assessment of neuropsychological status in early Parkinson's diseaseChengwu Yang, Elizabeth Garrett-Mayer, Jay S Schneider, et al.
Shock (Augusta, Ga.)|February 17, 2017
Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured PatientsErin E Fox, John B Holcomb, Charles E Wade, et al.
The Journal of Rheumatology|October 6, 2005
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosisPaul J Nietert, Richard M Silver, Holly C Mitchell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 5, 2022
Inclusion of Non-English-Speaking Participants in Studies of Parkinson's Disease: A Call to ActionKathleen E McKee, Rebecca M Gilbert, Wendy A Spigle, et al.
Stroke|September 9, 2006
Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke StudyEdward C Jauch, Christopher Lindsell, Joseph Broderick, et al.
Parkinsonism & Related Disorders|August 12, 2008
Minority enrollment in Parkinson's disease clinical trialsMyra G Schneider, Christopher J Swearingen, Lisa M Shulman, et al.
Movement Disorders Clinical Practice|October 18, 2016
IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRSChristopher G Goetz, Glenn T Stebbins, Lu Wang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Handling missing values in the MDS-UPDRSChristopher G Goetz, Sheng Luo, Lu Wang, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Stroke|October 15, 2005
Applying a phase II futility study design to therapeutic stroke trialsYuko Y Palesch, Barbara C Tilley, David L Sackett, et al.
Parkinsonism & Related Disorders|August 25, 2014
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRSJennifer G Goldman, Glenn T Stebbins, Vania Leung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Repeatable battery for assessment of neuropsychological status in early Parkinson's diseaseChengwu Yang, Elizabeth Garrett-Mayer, Jay S Schneider, et al.
Shock (Augusta, Ga.)|February 17, 2017
Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured PatientsErin E Fox, John B Holcomb, Charles E Wade, et al.
The Journal of Rheumatology|October 6, 2005
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosisPaul J Nietert, Richard M Silver, Holly C Mitchell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 5, 2022
Inclusion of Non-English-Speaking Participants in Studies of Parkinson's Disease: A Call to ActionKathleen E McKee, Rebecca M Gilbert, Wendy A Spigle, et al.
Stroke|September 9, 2006
Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke StudyEdward C Jauch, Christopher Lindsell, Joseph Broderick, et al.
Parkinsonism & Related Disorders|August 12, 2008
Minority enrollment in Parkinson's disease clinical trialsMyra G Schneider, Christopher J Swearingen, Lisa M Shulman, et al.
Movement Disorders Clinical Practice|October 18, 2016
IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRSChristopher G Goetz, Glenn T Stebbins, Lu Wang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Handling missing values in the MDS-UPDRSChristopher G Goetz, Sheng Luo, Lu Wang, et al.
Pageof 11